| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Biopharm Division | $2.47M | $2.59M | $2.52M | $2.7M | $2.61M |
| Neuromodulation Division | $221K | $298K | $296K | — | $390K |
| Neurostimulation Division | $284.75K | $284.75K | $284.75K | $284.75K | — |
| Total | — | — | — | — | — |
Neurostimulation Division is derived from annual filings.